It is possible that changes in PCSK6 activity alter lipid metabolism and therefore have downstream effects on PAD or altered PCSK6 activity may effect LDL-C and PAD separately through independent mechanisms. The gene discussed is PCSK6; the disease is peripheral arterial disease.